Health & Wellness

Press Releases

Rafael Pharmaceuticals, in Collaboration with Atlantic Health System, Announces Initiation of a Phase I Study of CPI-613 in Combination with Gemcitabine and Nab-Paclitaxel for Patients with Locally Advanced or Metastatic Pancreatic Cancer

a07d2d57403ac43db2c4_Dr._Angela_Alistar_2017.jpg
a07d2d57403ac43db2c4_Dr._Angela_Alistar_2017.jpg

Rafael Pharmaceuticals, Inc., a clinical stage company and leader in the field of cancer metabolism-based therapeutics, announced today, the initiation of a Phase I clinical trial of CPI-613 in combination with chemotherapeutic agents, gemcitabine and nab-paclitaxel, for patients with locally advanced or metastatic pancreatic cancer. The study will be conducted in collaboration with Atlantic Health System. CPI-613 is a first-in-class drug with a unique mode of action and is Rafael’s lead altered energy metabolism directed (AEMD) drug candidate. The drug is designed to disrupt the altered energy-production pathways in cancer cells by targeting their mitochondrial metabolism.

The primary aim of the study is to establish the maximum tolerated dose of CPI-613 when given in combination with gemcitabine/nab-paclitaxel for patients with locally advanced or metastatic pancreatic cancer.

Secondary aims include:

Sign Up for E-News

(1) To describe the safety profile for the gemcitabine/nab-paclitaxel/CPI-613 combination.
(2) To determine the clinical activity of gemcitabine/nab-paclitaxel/CPI-613 in metastatic pancreatic cancer as measured by tumor response rate (RR) by RECIST criteria, progression-free survival (PFS), and overall survival (OS).

Encouraging results observed in earlier trials, including Phase I data from a trial led by Angela Alistar, MD that was recently published in The Lancet Oncology, demonstrated the preliminary efficacy of CPI-613 in combination with modified FOLFIRINOX (a multidrug treatment for advanced pancreatic cancer) in patients with metastatic pancreatic cancer. These results support further evaluation of CPI-613 in this indication.[1] The safety profile of CPI-613 in earlier trials, which shows the drug to be well tolerated, provides further support for evaluation of CPI-613 in combination with other drugs to maximize benefit.

In 2013, the MPACT study, a multinational, phase III clinical trial comparing gemcitabine/nab-paclitaxel to gemcitabine alone, demonstrated an improved median survival of 8.5 months as compared with 6.7 months for gemcitabine monotherapy (p=0.000015). While some clinical benefit was shown, these outcomes also highlight the need for new combination strategies to improve upon the outcomes seen with gemcitabine/nab-paclitaxel in the treatment of metastatic pancreatic cancer.

Dr. Alistar, medical director of GI Medical Oncology at the Carol G. Simon Cancer Center of Morristown Medical Center, Atlantic Health System, and the Principal Investigator for this trial, remarked, “Strategies to enhance our current standard of care options are sorely needed in pancreatic cancer. Due to the low toxicity profile of CPI -613 as a single agent, I anticipate good tolerance in combination with the gemcitabine/nab-paclitaxel regimen. I am excited to be able to offer this novel option to our patients with pancreatic cancer. Targeting metabolism in pancreatic cancer has a strong scientific rationale.”

Sanjeev Luther, Rafael Pharmaceuticals’ Chief Executive Officer, commented, “Our company’s motto of “One Patient at a Time” is especially relevant in this situation. Patients with a low tolerance for toxicity may not be eligible for the FOLFIRINOX combo. We believe that the gemcitabine/nab-paclitaxel regimen has the potential to be a potent treatment with less toxicity. It is especially meaningful for us to announce the initiation of this study on World Pancreatic Cancer Day.”

About Atlantic Health System

Atlantic Health System, headquartered in Morristown, N.J., is an integrated health care delivery system powered by a workforce of 16,000 team members dedicated to building healthier communities. The system is comprised of 350 sites of care, including six hospitals: Morristown Medical Center, Overlook Medical Center, Newton Medical Center, Chilton Medical Center, Hackettstown Medical Center and Goryeb Children’s Hospital. Atlantic Health System also supports communities through Atlantic Medical Group, Atlantic Rehabilitation, Atlantic Home Care and Hospice, and its subsidiary, Atlantic Ambulance Corporation. Atlantic Health System sponsors the Atlantic Accountable Care Organization, one of the larger ACOs in the nation, and Optimus Healthcare Partners. 

About Rafael Pharmaceuticals, Inc.

Rafael Pharmaceuticals, Inc. is a clinical-stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Rafael’s primary objective is to develop highly selective and effective agents with minimal toxic effects on normal cells and tissues. Rafael’s first-in-class clinical lead compound, CPI-613 is being evaluated in multiple Phase I, I/II, and II clinical studies. The U.S. Food and Drug Administration (FDA) has given Rafael approval to initiate pivotal clinical trials in pancreatic cancer and acute myeloid leukemia (AML), and has designated CPI-613 an orphan drug for the treatment of pancreatic cancer, AML, and myelodysplastic syndromes (MDS). The company's investors include IDT Corporation (NYSE: IDT). For more information, visit http://www.rafaelpharma.com/.

Safe Harbor Statement

This press release contains forward-looking statements. These statements relate to future events or the company’s future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may", "will", "should", "expect", "plan", "anticipate", "believe", "estimate", "predict", "potential" or "continue", the negative of such terms, or other comparable terminology. These statements are only predictions. Actual events or results may differ materially from those in the forward-looking statements as a result of various important factors. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by the company, or any other person, that such forward-looking statements will be achieved. The business and operations of the company are subject to substantial risks which increase the uncertainty inherent in forward-looking statements. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements.

Reference

[1] Alistar A, Morris BB, Desnoyer R, et al. (2017). Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial. The Lancet Oncology. doi: 10.1016/S1470-2045(17)30314-5.

TAP Into Another Town's News:

You May Also Be Interested In

Sign Up for E-News

SOMA

Love is in the air...

Come to Sadie's to buy your sweetie the perfect Valentine's Day gift. We have locally made jewelry, vegan perfume, unique valentine cards, scratch off maps for those who travel and other fun gifts - something for every honey. Of course if you are looking for something to wear on your romantic night out or a fun single's night we have that, too.

Saturday, Feb 10, from noon to 3 ...

A Tale of Two Very Different Town Administrator Searches

Both Maplewood and South Orange are looking for new town administrators at the same time, a rare occurrence.

And their approaches couldn’t be any more different.

Maplewood, whose long-time administrator Joseph Manning is retiring May 31, launched its search last month the old-fashioned way: hiring a recruiting firm and letting them do the heavy lifting (or more appropriately the ...

AtlantiCast

AtlantiCast Medical Minute: Atlantic Orthopedic Institute’s Scoliosis and Spinal Deformity Center

On this episode of the AtlantiCast Medical Minute, we’ll take you inside the Atlantic Orthopedic Institute’s Scoliosis and Spinal Deformity Center, with the center’s director, Jason Lowenstein, MD.

Video Link: https://www.youtube.com/watch?v=1M7euCp86-c

AtlantiCast Episode 011

Breaking Atlantic Health System news on this week’s AtlantiCast! Plus, find out why Morristown Medical Center is one of the best hospitals in the nation when it comes to recovering from joint surgery, see the newest center for fighting brain cancer and an Atlantic Health System red-carpet premiere!

 

South Orange Police Blotter - Two Arrested for Robbery in South Orange

February 11, 2018

Adult Arrest - Robbery - Shawn Ray Newsome, a 20 year old Newark resident and a 17 year old juvenile were arrested on Saturday, Feb. 3, at approximately 10:45 p.m. for robbery. Two male victims reported that as they were walking on South Orange Ave near the Newark border, they were approached by three actors (described as black males wearing dark clothing and black masks) who ...

Maplewood Police Blotter - Home Burglary and Two Auto Thefts Reported

January 29 - Burglary; At approximately 3:10 p.m., officers responded to the area of Heller Pl and Orchard Rd on the report of an individual going into backyards. While checking the area, a juvenile approached an officer and notified her that her home on Orchard Rd had just been entered by an unknown male. Officers checked the home and surrounding area, but were unable to ...

Voting Ends Feb. 20 for Discover Jersey Arts People's Choice Awards: 4 Nominations for South Orange

February 17, 2018

SOUTH ORANGE, NJ – Three arts organizations based in South Orange have been nominated for Discover Jersey Arts People's Choice Awards, and South Orange itself has been nominated for Favorite Downtown Arts District.

“We are thrilled that South Orange has been nominated as best Downtown Arts District for the first time," said Bob Zuckerman, Executive Director of the ...

Over 25 Camps Share What's Hot this Summer at the Second Annual SOMA Summer Camp Fair

MAPLEWOOD, NJ - Families from South Orange and Maplewood got the chance to learn about more than 25 area summer camps on Saturday, at the second annual SOMA Summer Camp Fair, hosted by Susie Adamson and Bonnie Ramsey of Adamson Ramsey Homes.

At the fair, which was held at Winchester Gardens, parents and kids could meet with representatives from a variety of camps, and learn more ...

Upcoming Events

Carousel_image_278e57ad2fc81cfdec30_hangermacrame

Sun, February 18, 2:00 PM

Sadie's, South Orange

Macrame Workshop at Sadie's

Arts & Entertainment Home & Garden

Sun, February 18, 3:00 PM

Lawton C. Johnson Summit Middle School, Summit

Come to NJIO's Winter Concert on Sunday, February ...

Arts & Entertainment

Wed, February 21, 12:00 PM

Temple Sharey Tefilo-Israel, South Orange

The Purposes and Rhythms of Jewish Living

Education Religions And Spirituality

PARCC Debate in Newark Continues Amid Calls from Murphy for its Dismantling

February 17, 2018

NEWARK, NJ - Ever since New Jersey began using the PARCC exam in the 2014-15 school year, the state teacher's union and other groups have criticized the the standardized test and called for the state to stop using it to assess student performance.

During the campaign for governor last year, Phil Murphy, who was endorsed by the New Jersey Education Association, promised to ditch ...

TV News Crews Descend on Nutley, Schools Closed as Precautionary Measure

NUTLEY, NJ - Hours after official notification about Nutley Public Schools being closed because of a threatening video on Instagram, television news crews descended on the township as the national discussion about school security took a local turn.

Nutley Public Schools and the Nutley Police Department confirmed the situation. The police also confirmed that the individuals ...

Rabid Raccoon Reported in Mountainside

February 17, 2018

MOUNTAINSIDE, NJ — The Westfield Veterinary Group and Wellness Center today warned clients Friday and posted on their Facebook page that a raccoon in Mountainside has been confirmed to have rabies. 

“Please be very careful with your pets and be sure that they are up to date on their rabies vaccinations,” it said. “If you should ...

Springfield's Cannon Ball House is Open to Public Sunday, Feb. 18, Letter from George Washington and Herbert Hoover on Display

SPRINGFIELD, NJ – Hit by a cannon ball, it survived the Revolutionary War. Sunday, Feb. 18, there is the Springfield Historical Society Open House at the Cannon Ball House. It will be open to the public from 2 p.m. to 4 p.m.  

In honor of it being Presidents’ Day weekend, two samples of presidential penmanship will be displayed. One is a letter that George ...

Man Charged with Crashing Truck into East Orange Planned Parenthood Clinic

February 17, 2018

Acting Essex County Prosecutor Robert D. Laurino and East Orange Public Safety Director Sheliah Coley announced on Friday that Marckles Alcius, 31, with a last known address in Lowell, Massachusetts, has been charged with carrying out a truck attack on the Planned Parenthood East Orange Health Clinic on February 14, 2018, using a stolen bakery delivery truck.

Alcius has been charged with ...

Paper Mill Playhouse Announces the World Premiere of 'Unmasked'

Paper Mill Playhouse (Mark S. Hoebee-Producing Artistic Director, Todd Schmidt-Managing Director), recipient of the 2016 Regional Theatre Tony Award, announced today the world premiere of UNMASKED, which will feature some of Andrew Lloyd Webber’s most iconic work and the stories behind its creation, along with new music and memories from his extraordinary life and career, will open its ...

Weekly Specials at Ashley Marketplace & Cafe - Feb. 16 to Feb. 22

Shop Ashley Marketplace & Cafe for your everyday needs!

This week's specials are:

Ground Beef or Pork $3.99lb (Meat)
Ito En Iced Teas 16.9floz  2/$4
Navel Oranges 5/$5
Swordfish Steaks $19.98lb (Ashley Fish Market)
Tropicana Punch $1.99
Turkey Hero $5.99ea (Deli)
Greek Feta $7.99lb (Cheese)
Chopped Chicken Salad $8.99lb (Prep Food)

See all ...